stella
beta
Trastuzumab Emtansine(T-DM1) After Trastuzumab Deruxtecan(T-DXd) in HER2-Positive Breast Cancer in Korea — Stella
Recruiting
Back to Cancer of Breast trials
Trial locations
(1 site)
South Korea
Seoul National University Hospital, Seoul
View full record on ClinicalTrials.gov